Evaluation of the Cerebral Oxygenation With Near Infrared Spectrophotometry (NIRS) at the Hypernatremic Dehydration in Newborn

NCT ID: NCT01299428

Last Updated: 2011-02-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

2 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-02-28

Study Completion Date

2011-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is to evaluate cerebral oxygenation with Near infrared spectrophotometry (NIRS) at the hypernatremic dehydration in newborns.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

HYPERNATREMIA

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SCREENING

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

cerebral oxygenation

Group Type ACTIVE_COMPARATOR

INVOS 5100

Intervention Type DEVICE

INVOS 5100 IS AN EQUIPMENT THAT MEASURED CEREBRAL OXYGENATION WITH NEAR INFRARED SPECTROPHOTOMETRY METHOD.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

INVOS 5100

INVOS 5100 IS AN EQUIPMENT THAT MEASURED CEREBRAL OXYGENATION WITH NEAR INFRARED SPECTROPHOTOMETRY METHOD.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* gestation week \> 37 ve Na \>150 mg/dl
* Dehydration

Exclusion Criteria

* Sepsis
* Intracranial Haemorrhagia
* Congenital Cardiac Diseases
Minimum Eligible Age

1 Day

Maximum Eligible Age

1 Month

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Zekai Tahir Burak Women's Health Research and Education Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Zekai Tahir Burak Maternity Teaching Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Zekai Tahir Burak Maternity Teaching Hospital

Ankara, Samanpazarı, Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

melek akar, M.D

Role: CONTACT

+905052550518

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

melek akar, M.D.

Role: primary

+905052550518

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

5

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Oral Rehydration Therapy in Burn Patients
NCT02124265 TERMINATED PHASE1
Water Deprivation Protocol
NCT01224704 COMPLETED NA
Kinetic Method to Detect Dehydration
NCT01062776 COMPLETED PHASE1